All Stories

  1. Increased expression of SSEA-4 on TKI-resistant non–small cell lung cancer with EGFR-T790M mutation
  2. Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA)
  3. Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
  4. Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer
  5. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
  6. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes
  7. Methods for the preparation of mammalian oligosaccharides and glycoconjugates.